v3.26.1
Basis of presentation (Tables)
12 Months Ended
Dec. 31, 2025
Basis of presentation  
Schedule of effect of the adjustment of the prior period information on the Consolidated Financial Statements

Consolidated Balance Sheets

As at December 31, 2024

As reported in the financial statements

As adjusted in the financial statements 

USD’000, except par value

  ​ ​ ​

ended December 31, 2024

  ​ ​ ​

ended December 31, 2025

Other current liabilities

 

283

 

1,659

Total current liabilities

 

15,517

 

16,893

TOTAL LIABILITIES

 

19,702

 

21,078

SHAREHOLDERS’ EQUITY

 

 

Additional paid-in capital

 

117,944

 

116,568

Total shareholders’ equity

 

77,864

 

76,488

TOTAL LIABILITIES AND EQUITY

 

97,566

 

97,566

Consolidated Statements of Changes in Shareholders’ Equity

As reported in the financial statements

As adjusted in the financial statements

ended December 31, 2024

ended December 31, 2025

  ​ ​ ​

Additional

  ​ ​ ​

  ​ ​ ​

Additional

  ​ ​ ​

USD’000

paid-in capital

Total equity

paid-in capital

Total equity

As at December 31, 2023

 

24,730

 

5,031

 

24,435

 

4,736

Share Purchase Agreements

 

75,554

 

76,302

 

74,674

 

75,422

Warrant exercises

 

17,512

 

17,610

 

17,311

 

17,409

As at December 31, 2024

 

117,944

 

77,864

 

116,568

 

76,488

Consolidated Statements of Cash Flows

As reported in the financial 

As adjusted in the financial 

statements ended December 31, 2024

statements ended December 31, 2025

12 months ended December 31,

12 months ended December 31,

USD’000

  ​ ​ ​

2024

  ​ ​ ​

2023

  ​ ​ ​

2024

  ​ ​ ​

2023

Cash Flows from operating activities:

 

  ​

 

  ​

 

  ​

 

  ​

Increase / (decrease) in other current liabilities, excluding stock-based compensation liability

 

145

 

(10)

 

1,226

 

285

Net cash provided by / (used in) operating activities

 

(11,205)

 

(3,040)

 

(10,124)

 

(2,745)

Cash Flows from financing activities:

 

  ​

 

  ​

 

  ​

 

  ​

Common Stock issuance costs

 

(4,855)

 

 

(5,936)

 

(295)

Net cash provided by / (used in) financing activities

 

89,481

 

8,920

 

88,400

 

8,625